Aromatase inhibitors and selective estrogen receptor modulators: Unconventional therapies for functional hypogonadism?

AIs are not recommended as treatment for functional hypogonadism because of insufficient efficacy as well as a decrease in BMD. SERMs might be an alternative for TRT, but more research is needed to evaluate their effect on hypogonadal signs and symptoms, as well as on their long-term safety profile.